[Late results of treatment of chronic pulmonary tuberculosis with ethambutol and capreomycin]. 1973

E Polaczek, and E Lachowicz, and W Araszkiewicz, and H Kozakow, and A Kazimierczak, and A Pszonicka, and M Potworowska, and M Janowiec, and H Styszewska, and H Klimkiewicz, and R Grabowska

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002207 Capreomycin Cyclic peptide antibiotic similar to VIOMYCIN. It is produced by Streptomyces capreolus. Capreomycin Sulfate,Capastat,Capromycin
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004977 Ethambutol An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863) Dexambutol,EMB-Fatol,EMB-Hefa,Etambutol Llorente,Ethambutol Hydrochloride,Etibi,Miambutol,Myambutol,EMB Fatol,EMB Hefa,Hydrochloride, Ethambutol,Llorente, Etambutol
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E Polaczek, and E Lachowicz, and W Araszkiewicz, and H Kozakow, and A Kazimierczak, and A Pszonicka, and M Potworowska, and M Janowiec, and H Styszewska, and H Klimkiewicz, and R Grabowska
January 1970, Polish medical journal,
E Polaczek, and E Lachowicz, and W Araszkiewicz, and H Kozakow, and A Kazimierczak, and A Pszonicka, and M Potworowska, and M Janowiec, and H Styszewska, and H Klimkiewicz, and R Grabowska
July 1969, Gruzlica i choroby pluc; tuberculosis et pneumonologia,
E Polaczek, and E Lachowicz, and W Araszkiewicz, and H Kozakow, and A Kazimierczak, and A Pszonicka, and M Potworowska, and M Janowiec, and H Styszewska, and H Klimkiewicz, and R Grabowska
May 1968, Diseases of the chest,
E Polaczek, and E Lachowicz, and W Araszkiewicz, and H Kozakow, and A Kazimierczak, and A Pszonicka, and M Potworowska, and M Janowiec, and H Styszewska, and H Klimkiewicz, and R Grabowska
January 1969, Acta tuberculosea et pneumologica Belgica,
E Polaczek, and E Lachowicz, and W Araszkiewicz, and H Kozakow, and A Kazimierczak, and A Pszonicka, and M Potworowska, and M Janowiec, and H Styszewska, and H Klimkiewicz, and R Grabowska
January 1969, Beitrage zur Klinik und Erforschung der Tuberkulose und der Lungenkrankheiten,
E Polaczek, and E Lachowicz, and W Araszkiewicz, and H Kozakow, and A Kazimierczak, and A Pszonicka, and M Potworowska, and M Janowiec, and H Styszewska, and H Klimkiewicz, and R Grabowska
April 1966, Annals of the New York Academy of Sciences,
E Polaczek, and E Lachowicz, and W Araszkiewicz, and H Kozakow, and A Kazimierczak, and A Pszonicka, and M Potworowska, and M Janowiec, and H Styszewska, and H Klimkiewicz, and R Grabowska
May 1969, The American review of respiratory disease,
E Polaczek, and E Lachowicz, and W Araszkiewicz, and H Kozakow, and A Kazimierczak, and A Pszonicka, and M Potworowska, and M Janowiec, and H Styszewska, and H Klimkiewicz, and R Grabowska
September 1967, Prensa medica argentina,
E Polaczek, and E Lachowicz, and W Araszkiewicz, and H Kozakow, and A Kazimierczak, and A Pszonicka, and M Potworowska, and M Janowiec, and H Styszewska, and H Klimkiewicz, and R Grabowska
January 1968, Scandinavian journal of respiratory diseases. Supplementum,
E Polaczek, and E Lachowicz, and W Araszkiewicz, and H Kozakow, and A Kazimierczak, and A Pszonicka, and M Potworowska, and M Janowiec, and H Styszewska, and H Klimkiewicz, and R Grabowska
January 1969, Acta tuberculosea et pneumologica Belgica,
Copied contents to your clipboard!